Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-02, Stock:ABBV, The news for the past five days is as follows:
2018-01-26: NEWS1: Intel and AbbVie jump while Starbucks and Colgate skid.NEWS2: [$$] AbbVie Says Tax Overhaul Will Slash 2018 Effective Tax Rate to 9%.NEWS3: What Happened in the Stock Market Today.NEWS4: The Hot Stock & Biggest Loser: AbbVie & Wynn Resorts.NEWS5: US STOCKS-Intel, healthcare shares boost lift Wall St to record.NEWS6: US STOCKS SNAPSHOT-Wall St climbs to new highs on strong Intel, AbbVie earnings.NEWS7: AbbVie Inc Stock Soars on Strong Q4 Earnings Beat.NEWS8: Here's Why AbbVie's Stock Is Skyrocketing 12.6% Today.NEWS9: This Is By Far the Most Important Number in AbbVie's Q4 Results.NEWS10: Here&apos;s Why AbbVie&apos;s Stock Is Skyrocketing 12.6% Today.NEWS11: 5 Biotech and Pharmaceutical Stocks Going Bonkers.NEWS12: How AbbVie Makes its Money.NEWS13: Blue-Chip Drug Stock, Dow Jones Name Boasts Big Yield, Hits 13-Year High.NEWS14: AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up.NEWS15: This Is By Far the Most Important Number in AbbVie&apos;s Q4 Results.NEWS16: AbbVie Needs to Plan for Harsher Post-Humira World.NEWS17: US Stocks Extend Gains as Health Care, Tech Sectors Edge Higher.NEWS18: Q4 GDP Sub-3%, Q4 Earnings Roll On.NEWS19: A Spate of Q4 Earnings.NEWS20: AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up.NEWS21: AbbVie Inc Stock Soars on Strong Q4 Earnings Beat.NEWS22: US STOCKS-S&P, Dow hit records on upbeat Intel, AbbVie earnings.NEWS23: AbbVie (ABBV) Q4 Earnings & Revenues Beat, Guidance Raised.NEWS24: S&P 500 Movers: CL, ABBV.NEWS25: Stocks Rally To New Record Closing Highs - U.S. Commentary.NEWS26: Stocks Rally To New Record Closing Highs - U.S. Commentary.NEWS27: Will J&J (JNJ) Witness Deceleration in 2018 Sales Growth?.NEWS28: Novartis Gets Spark Therapeutics' Luxterna License Outside US.NEWS29: Morning Movers: AbbVie Jumps on Earnings, Colgate Crushed, Gilead Rising.NEWS30: Don't Give Up on Gilead Yet.NEWS31: A Spate of Q4 Earnings.NEWS32: US STOCKS-Dow hits record on Intel earnings.NEWS33: AbbVie (ABBV) Q4 Earnings & Revenues Beat, Guidance Raised.NEWS34: Novartis Gets Spark Therapeutics&apos; Luxterna License Outside US.NEWS35: Will J&J (JNJ) Witness Deceleration in 2018 Sales Growth?.NEWS36: AbbVie shares rise 3% after Q4 profit, revenue beats, upbeat guidance.NEWS37: AbbVie’s Q4 Boosted by Strong Segment Results.NEWS38: Benzinga Pro's 6 Stocks To Watch Today.NEWS39: AbbVie beats Street 4Q forecasts.NEWS40: AbbVie's quarterly profit plunges on $1.14 bln tax charge.NEWS41: AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results.NEWS42: 3 Promising Stocks to Buy in 2018.NEWS43: How Is Novartis’s Subsidiary Sandoz Positioned for 2018?.NEWS44: Stocks Hovering In Positive Territory In Mid-Day Trading - U.S. Commentary.NEWS45: Stocks Hovering In Positive Territory In Mid-Day Trading - U.S. Commentary.NEWS46: AbbVie (ABBV) Has Surged To A New High On Better Than Expected Q4 Earnings.NEWS47: AbbVie (ABBV) Has Surged To A New High On Better Than Expected Q4 Earnings.
2018-01-29: NEWS1: Novartis' Lutathera Gets FDA Approval for Pancreatic Tumors.NEWS2: Novartis' Lutathera Gets FDA Approval for Pancreatic Tumors.NEWS3: Roche Hemophilia Drug Hemlibra Gets Positive CHMP Opinion.NEWS4: Roche Hemophilia Drug Hemlibra Gets Positive CHMP Opinion.NEWS5: Novartis&apos; Lutathera Gets FDA Approval for Pancreatic Tumors.NEWS6: AbbVie Shares Double In A Year; Leerink Moves To Sidelines.NEWS7: Roche Hemophilia Drug Hemlibra Gets Positive CHMP Opinion.NEWS8: Notable ETF Inflow Detected - MTUM, BA, C, ABBV.NEWS9: Notable ETF Inflow Detected - MTUM, BA, C, ABBV.NEWS10: AstraZeneca's Triple Combo COPD Inhaler Positive in Phase III.NEWS11: AstraZeneca's Triple Combo COPD Inhaler Positive in Phase III.NEWS12: Stock Market News for Jan 29, 2018.NEWS13: Stock Market News for Jan 29, 2018.NEWS14: 3 Things Driving AbbVie Inc. Stock After Q4 Earnings Report.NEWS15: AstraZeneca&apos;s Triple Combo COPD Inhaler Positive in Phase III.NEWS16: Why Marijuana and Cryptocurrency Investments Differ.NEWS17: AbbVie (ABBV) Soars on Q4 Results: Key Takeaways from the Earnings Call.NEWS18: Strength Seen in AbbVie (ABBV): Stock Soars 13.8%.NEWS19: Strength Seen in AbbVie (ABBV): Stock Soars 13.8%.NEWS20: Stock Market News for Jan 29, 2018.NEWS21: Morning Movers: Dr. Pepper Soars on Keurig Merger; Seagate Technology Climbs on Earnings.NEWS22: What to Expect in Pfizer's Q4 Earnings Results.NEWS23: AbbVie Could Climb Even Higher.NEWS24: Strength Seen in AbbVie (ABBV): Stock Soars 13.8%.NEWS25: Today’s Research Reports on Stocks to Watch: AbbVie Inc. and Pfizer Inc..NEWS26: AbbVie (ABBV) Soars on Q4 Results: Key Takeaways from the Earnings Call.NEWS27: Why Dividend Investors Want to Own AbbVie in 2018.NEWS28: 3 Things Driving AbbVie Inc. Stock After Q4 Earnings Report.NEWS29: [$$] AbbVie Gives More Juice to Drug Rally.
2018-01-30: NEWS1: Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX.NEWS2: HCA Healthcare's (HCA) Q4 Earnings, Revenues Beat Estimates (Revised).NEWS3: HCA Healthcare's (HCA) Q4 Earnings, Revenues Beat Estimates (Revised).NEWS4: Top Stock Reports for Bank of America, Citigroup & AbbVie.NEWS5: HCA Healthcare&apos;s (HCA) Q4 Earnings, Revenues Beat Estimates (Revised).NEWS6: Analysts Take Action on Healthcare Stocks.NEWS7: Pfizer sees upbeat 2018 on lower tax rate, shares dip after highs.NEWS8: 3 Big Biotech Stocks With Major Catalysts on the Way.NEWS9: 3 Big Biotech Stocks With Major Catalysts on the Way.NEWS10: Pfizer profit tops estimates, books $11 bln tax gain.NEWS11: 3 Big Biotech Stocks With Major Catalysts on the Way.
2018-01-31: NEWS1: Vertex Beats Views, Closes In On Cystic Fibrosis Treatments.NEWS2: Vertex Beats Views, Closes In On Cystic Fibrosis Treatments.NEWS3: Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks.NEWS4: Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks.NEWS5: Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks.NEWS6: Despite Tax-Cut, Pfizer Inc. Remains a Slow-Growth Company.NEWS7: Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance.NEWS8: Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance.NEWS9: AbbVie Is Ruining Pharma Earnings Season.NEWS10: The Zacks Analyst Blog Highlights: Bank of America, Citigroup, AbbVie, 3M, Starbucks and Halliburton.NEWS11: The Zacks Analyst Blog Highlights: Bank of America, Citigroup, AbbVie, 3M, Starbucks and Halliburton.NEWS12: Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View.NEWS13: Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View.NEWS14: Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance.NEWS15: Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues &apos;18 View.NEWS16: The Zacks Analyst Blog Highlights: Bank of America, Citigroup, AbbVie, 3M, Starbucks and Halliburton.NEWS17: Johnson & Johnson’s Medical Devices Business in 4Q17.NEWS18: The Best Arthritis Drug/Treatment Stocks on the Market Right Now.NEWS19: The Best Arthritis Drug/Treatment Stocks on the Market Right Now.NEWS20: The Best Arthritis Drug/Treatment Stocks on the Market Right Now.NEWS21: Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX.NEWS22: Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX.
2018-02-01: NEWS1: Top 4 Marijuana Stocks to Watch.NEWS2: 5 Best Performing Stocks of January.NEWS3: 5 Best Performing Stocks of January.NEWS4: A Look at Analysts’ Estimates for Johnson & Johnson.NEWS5: Will Gilead (GILD) Disappoint Investors in Q4 Earnings?.NEWS6: Will Gilead (GILD) Disappoint Investors in Q4 Earnings?.NEWS7: Merck’s 4Q17 Estimates: Animal Health.NEWS8: Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi.NEWS9: Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi.NEWS10: Will Gilead (GILD) Disappoint Investors in Q4 Earnings?.NEWS11: Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi.NEWS12: Wired News – Shire Secured Exclusive Worldwide License to Develop and Commercialize AB Biosciences’ PRIM Program.NEWS13: Cramer Remix: Here are the best-in-show biotechs for 2018....NEWS14: Cramer Remix: AbbVie and Biogen are the best-in-show biotechs for 2018 so far.

Answer: Decrease